BioLegacy Research
Private Company
Funding information not available
Overview
BioLegacy Research is a privately held, revenue-generating preclinical CRO founded in 2001 with a 25-year operational history in San Diego. The company provides a full suite of services from early discovery to IND submission, with particular strengths in non-human primate studies, complex surgical models for medical device testing, and custom assay development. It serves biotechnology and pharmaceutical companies developing therapeutics across numerous disease areas, including oncology, immunology, neurology, and rare diseases, by offering agile, compliant study execution with integrated bioanalytical capabilities.
Technology Platform
Integrated preclinical research platform featuring a wide-range vivarium (specializing in non-human primates), a surgical suite for medical device testing, on-site bioanalytical capabilities, custom animal model and assay development, and expertise in GLP-compliant IND-enabling study design and execution.
Opportunities
Risk Factors
Competitive Landscape
Operates in the highly competitive preclinical CRO market, competing against large, full-service global players (e.g., Charles River, Labcorp) and smaller niche specialists. Differentiation is based on deep expertise in non-human primates, surgical device testing, custom model development, and a client-centric, agile service model from its San Diego base.